Appetizer  
 TRADITIONAL GERMAN HAUS SALAD 
 Salad of Mixed Greens with a Raspberry Walnut Vinaigrette 
 Entrée 
 BAVARIAN SAUERBRATEN 
 Pot roast of Beef Marinated in Burgundy Wine, Vinegar and  
 Spices, Served with German Potato Pancakes and Red  
 Cabbage 
 GERMAN KNOCKWURST PLATTER 
 German Sausage Served with Sauerkraut Potato Pancake  
 and Mustard 
 PORK SCHNITZEL 
 Tenderized and Breaded Pork Loin, Pan Fried and Served  
 with Red Cabbage and Potato Pancake 
 GERMAN STYLE STUFFED CABBAGE 
 Served with Sauerkraut Mustard and Potato Pancake 
 BEEF GOULASH 
 Served with Traditional Egg Noodles 
 Dessert  
 HOMEMADE HOT APPLE STRUDEL  
 COURIER L 42     IFE, OCT. 9-15, 2020 
 Determining the stage of the cancer helps patients and their doctors fi gure out the prognosis, 
  develop a treatment plan and even decide if clinical trials are a valid option. 
 How to determine the  
 stage of breast cancer 
 When  receiving  treatment  for  
 breast cancer, women will learn about  
 cancer  staging. According  to the nonprofi  
 t organization Breastcancer.org,  
 determining the stage of the  
 cancer  helps  patients  and  
 their doctors fi gure  out  the  
 prognosis, develop a treatment  
 plan, and even decide  
 if clinical trials are a valid  
 option. 
 Typically expressed as  
 a number on a scale of 0  
 through IV, breast-cancer  
 stage  is  determined  after  
 careful consideration of a  
 host of factors. The staging system,  
 sometimes referred to as the TNM  
 system, is overseen by the American  
 Joint Committee on Cancer and ensures  
 that all instances of breast cancer  
 are described in a uniform way.  
 This helps to compare treatment results  
 and gives doctors and patients a  
 better understanding of breast cancer  
 and the ways to treat it. 
 Breastcancer.org  notes  that  the  
 TNM system was updated in 2018, but  
 before then was based on three clinical  
 characteristics: 
 T: The size of the tumor and whether  
 or not it has grown into nearby tissue. 
 N: Whether the cancer is present in  
 the lymph nodes. 
 M: Whether the cancer has metastasized, 
  or spread to others parts of the  
 body beyond the breast. 
 Each of those factors is still considered  
 when  determining  breast  cancer  
 stage, but starting in 2018, the AJCC  
 added additional characteristics to its  
 staging guidelines, which make staging  
 more complex but also more accurate: 
 Tumor grade  
 This is a measurement of how much  
 the cancer cells look like normal cells. 
 Estrogen- and progesteronereceptor  
 status  
 This indicates if the cancer cells  
 have receptors for the hormones estrogen  
 and progesterone. If cancer  
 cells are deemed estrogen-receptorpositive, 
  then they may receive signals  
 from estrogen that promote their  
 growth.  Similarly,  those  deemed  progesterone 
 receptor-positive may receive  
 signals from progesterone  
 that  could  promote  
 their growth.  
 Testing for hormone receptors, 
  which roughly two  
 out of three breast cancers  
 are positive for, helps doctors  
 determine if the cancer  
 will respond to hormonal  
 therapy or other treatments.  
 Hormone-receptor-positive  
 cancers may be treatable  
 with  medications  that  reduce  hormone  
 production or block hormones  
 from supporting the growth and function  
 of cancer cells. 
 HER2 status  
 This helps doctors determine if the  
 cancer cells are making too much of the  
 HER2 protein. HER2 proteins are receptors  
 on breast cells made by the HER2  
 gene. In about 25 percent of breast cancers, 
  the HER2 gene makes too many  
 copies of itself, and these extra genes  
 ultimately make breast cells grow and  
 divide in ways that are uncontrollable.  
 HER2-positive breast cancers are more  
 likely to spread and return than those  
 that are HER2-negative. 
 Oncotype DX score  
 The oncotype DX score helps doctors  
 determine a woman’s risk of  
 early stage, estrogen-receptor-positive  
 breast cancer recurring and how likely  
 she is to benefi t from post-surgery chemotherapy. 
  In addition, the score helps  
 doctors fi gure out if a woman is at risk  
 of ductal carcinoma in situ recurring  
 or at risk for a new invasive cancer developing  
 in the same breast. The score  
 also helps doctors fi gure  out  if  such  
 women will benefi t from radiation  
 therapy or DCIS surgery. 
 Determining  breast-cancer  stage  
 is a complex process, but one that can  
 help doctors develop the most effective  
 course of treatment. More information  
 is available at www.breastcancer.org. 
 OCTOBER 8TH 
 TO SUNDAY OCTOBER 20TH 
 $2995 PER PERSON  
 PLUS TAX & GRATUITY 
 LIVE MUSIC ON WEEKENDS • VALET PARKING 
 WWW.HUNTERSSTEAKHOUSE.COM 
 
				
/Breastcancer.org
		/Breastcancer.org
		/www.breastcancer.org
		/www.breastcancer.org
		/WWW.HUNTERSSTEAKHOUSE.COM